Autres langues ABL Diagnostics

Actions

ABLD

FR001400AHX6

Equipement, fournitures et distribution médicale

Marché Fermé - Euronext Paris 17:55:00 10/09/2026			Varia. 5j.	Varia. 1 janv.
2,400 ^EUR	-6,98%		+2,56%	-20,00%

19:21	Abionyx Pharma conclut un partenariat stratégique avec TEXCELL (ABL Diagnostics) pour la sécurité virale et la clairance des produits biologiques	CI
18:16	ABL Diagnostics s'associe à Abionyx Pharma

Autres langues

19:21	Abionyx Pharma Enters into Strategic Partnership with TEXCELL (Abl Diagnostics) for Viral Safety and Clearance of Biologics
18:01	ABL Diagnostics - TEXCELL Strengthens Its Position as an International Reference in Safety and Viral Clearance With a New Strategic Partnership With ABIONYX Pharma
08/09	ABL Diagnostics Maintains Revenue Guidance for the Financial Year 2026
08/09	ABL Diagnostics Confirms Its Change of Scale in the First Half of 2026: Revenue up 90.0%, EBITDA Multiplied by More Than Four and Net Income up 343.3% Compared to the First Half of 2025
08/09	ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2026
27/08	ABL Diagnostics: Ordinary and Extraordinary General Meeting of September 17, 2026 – Arrangements for the Availability and Consultation of Preparatory Documents
10/08	ABL Diagnostics Plans Listing Transfer to Euronext Growth Paris
07/08	ABL Diagnostics - Proposed Transfer of the Listing of Its Securities From the Regulated Market of Euronext Paris to Euronext Growth Paris
29/07	ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL
27/07	ABL Diagnostics Announces Amendment to the Equity Line and Share Loan Agreement Between Its Main Shareholder ABL SA (Luxembourg) and Alumni Capital
23/07	French Court OKs ABL Diagnostics' Industrial Plan to Acquire Texcell
23/07	ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL’s Operations
23/07	ABL Diagnostics Société anonyme agreed to acquire Assets and Business Operations from Texcell SA for ?0.78 million.
22/07	ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL
15/07	ABL Diagnostics Informed that its Reference Shareholder ABL Has Crossed Below the 95% Threshold
10/07	ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL
02/07	ABL Diagnostics – Approval of Dividend Distribution for Fiscal Year 2025
02/07	Abl Diagnostics Société Anonyme Approves Dividend Distribution for Fiscal Year 2025, Payable on July 7, 2026
18/06	ABL Diagnostics: Growth Trajectory Confirmed and Strong Upside Potential Identified
12/06	Abl Diagnostics Sa and Cdl Pharma Secure Multi-Year International Contract of Up to Eur 2.7 Million Through 2031
12/06	ABL Diagnostics Signs Multi-year Contract to Provide Clinical Trial Services
12/06	ABL Diagnostics and CDL Pharma Secure a Multi-year International Contract of up to €2.7 Million Through 2031
10/06	ABL Diagnostics Offers to Buy Texcell
10/06	ABL Diagnostics (ABLD) Announces the Submission of a Takeover Bid for Texcell France
09/06	ABL Diagnostics: Ordinary and Extraordinary General Meeting of June 30, 2026 – Terms for Making Available or Consulting Preparatory Documents